Jan. 25, 2023 Price forecast | 2 weeks: -1.78% | 1 month: -0.46% | 3 months: -5.75%


MYGN stock forecast

Our latest prediction for Myriad Genetics, Inc.'s stock price was made on the Jan. 25, 2023 when the stock price was at 20.51$.

In the short term (2weeks), MYGN's stock price should underperform the market by -1.78%. During that period the price should oscillate between -7.37% and +5.89%.

In the medium term (3months), MYGN's stock price should underperform the market by -5.75%. During that period the price should oscillate between -19.53% and +15.26%.

Create a solid portfolio with MYGN

Add MYGN to your portfolio and optimize it!


About Myriad Genetics, Inc.

Myriad Genetics Inc., is a leading genetic testing and precision medicine company dedicated to transforming patient lives worldwide. Myriad discovers and commercializes genetic tests that: determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across medical specialties where molecular diagnostics can significantly improve patient care and lower healthcare costs.

At the moment the company generates 190M USD in revenues.

On its last earning announcement, the company reported a loss of -0.95$ per share.

The book value per share is 13.61$

Myriad Genetics, Inc. website


Three months stock forecastJan. 25, 2023


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
190M 80.96% -131M -69.13% -77M -0.95 - - 80M 13.61 - - -